CD24 and neoplasm: Recently, CD24 was shown to promote immune evasion through its interaction with the inhibitory receptor Siglec-10 expressed by tumor-associated macrophages, revealing CD24 as a potent antiphagocytic (“don’t eat me”) signal in several cancers and demonstrating the therapeutic potential for CD24 blockade in cancer immunotherapy [8].